The Scientist - Home

Clnical Medicine Research, 1990-94 VS 1981-85. (Ranked by the magnitude of change among those publishing 1,000 or more papers, 1990-94) Institution Percent Change University of Texas, San Antonio +78 Oregon Health Sciences University +74 State University of New York, Stony Brook +70 Louisiana State University +65 University of Nebraska +63 University of Miami +62 City University of New York +61 Loyola University +61 Tulane University +61 Wake Forest University +57 Northwestern University +55 Un

Association Of Independent Research Institutes Honors Retired Director Of NIH Grants Division With New Award Author: Karen Young Kreeger Jerome Green, director of the National Institutes of Health's Division of Research Grants from 1986 to his retirement in June, was honored last month by the Association of Independent Research Institutes (AIRI) for distinguished service to the grantee community. Green received the $2,000 award, which was given for the first time, at the association's annual me

Their Fields Author: Neeraja Sankaran SIDEBAR: Technology Medalists Life scientists whose work has shed new light on genetic disorders and the basic mechanisms and structure of RNA were prominent among the individuals President Clinton presented with the National Medals of Science on October 18. The medals-the United States' highest scientific honor-were given to seven men and one woman. The event also featured the awarding of the National Medal of Technology to three scientists and business

ON THE BLOCK: An Ig Nobel celebrant won a date with Nobelist Dudley Herschbach. The Annals of Improbable Research followed tradition in its "Fifth First Annual Ig Nobel Prize Ceremony," honoring the 1995 Ig Nobel laureates with its own special version of pomp. Prizes-awarded to those whose achievements "cannot or should not be reproduced"-were presented by Nobelists Sheldon Glashow (physics 1979), Dudley Herschbach (chemistry 1986), Joseph Murray (physiology or medicine 1990), and Richard Robe

In Technology Transfer Author: Robert Finn An ongoing legal battle between Michigan State University (MSU) and the entities contracted to administer several of its highly lucrative patents has raised concerns among intellectual-property experts. These observers fear the dispute may cause a crisis in confidence among investors-and may further wrap inventors in red tape-in the rapidly burgeoning field of university technology transfer. NO NEED: MSU's Frederic Erbisch contends his school can han

Company Product Function Date Alza Corp., DynaCirc CR formulation of July 1994 Palo Alto, CA controlled-release antihypertensive drug Hybritech Inc., Tandem PSA detection of prostate Aug. 1994 San Diego cancer Molecular Bio- Albunex ultrasound Aug. 1994 systems Inc. contrast agent San Diego for detecting heart disease DNX Inc., BIODIGM reduction of LDLs Sept.1994 Princeton, NJ Quadra Logic Photofrin photosensitive drug Sept. 1994 Technologies Inc. for photodynamic Vancouver, BC therapy Canada

The recipients of the 1995 National Medals of Technology included two corporations, a team of three scientists from one company, and three other individuals. Like their science medal counterparts, the technology medals represent the United States' highest honor for achievement in technology. This year's winners are: A three-member team at IBM's T.J. Watson Research Center in Yorktown Heights, N.Y., consisting of Praveen Chaudhari, Jerome C. Cuomo (retired), and Richard Gambino (retired), for t

Struggles With Questions Of Leader's Role Author: Bruce V. Bigelow The Salk Institute has long been known as a premier center for biomedical research, but lately the San Diego laboratory has acquired a reputation in scientific circles as the home of hungry headhunters. Efforts by the independent, nonprofit laboratory to recruit and retain a new leader over the past seven years have repeatedly misfired. The Salk's fruitless quest hit home again on September 1, when Francis Crick stepped down f

SIDEBAR: Alternate Paths to Xenotransplantation The tantalizing possibility of using a potentially unlimited supply of organs from animals to replace damaged human ones -- through xenotransplantation -- has, in just the past few years, jumped the divide from purely academic possibility to big-business likelihood. A half-dozen or so well-supported biotechnology companies have sprung into existence to pursue the creation of transgenic animals -- pigs with human genes, primarily -- or to develop

Sidebar:Projected Efforts of Congressional Budget Resolution on Nondefense R&D for the years 1995 to 2002. Analysts say funding cuts represent a shift in Congress away from traditionally 'reflexive' support for scientific initiatives Senate and House committees surprised many science-minded Americans last month when-after months of rumored cuts-they decided to sustain funding for nondefense medical and basic research through 1996. Few analysts were surprised, however, when the committees began

The Albert Lasker Medical Research Awards officially turn 50 this year and, by almost any measure, have a luster unsurpassed among American awards for biomedical research and second internationally only to the near-twice-as-old Nobel Prizes. The reason is obvious to many members of the jury and previous award winners. NEW ROLE: Lasker laureate Joseph L. Goldstein takes over as jury chair. "No award is better than its recipients," says Joseph L. Goldstein, winner of a Lasker in 1985 and a Nobe

On the 50th anniversary of the establishment of its prestigious Albert Lasker Medical Research Awards, the New York-based Albert and Mary Lasker Foundation added a United States senator to the six biomedical researchers-including five immunologists recognized for the same research subject-it chose to honor for their contributions to the medical sciences and research. The foundation's Public Service Award went to Sen. Mark Hatfield (R-Ore.), chairman of the Senate Appropriations Committee, for